NCT02601625 A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02600221 A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China Status COMPLETED Phase N/A
NCT02599714 Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT02597101 Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02588859 Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients Status COMPLETED Phase N/A
NCT02588131 A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) Status UNKNOWN Phase PHASE2
NCT02588105 Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02586987 A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT02585973 Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC Status COMPLETED Phase PHASE1
NCT02585804 Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects Status COMPLETED Phase PHASE4
NCT02583542 A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers Status UNKNOWN Phase PHASE1/PHASE2
NCT02583477 Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02582840 The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM Status COMPLETED Phase PHASE1
NCT02582814 The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM Status COMPLETED Phase PHASE3
NCT02579226 A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT02578563 Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore Status COMPLETED Phase N/A
NCT02574637 Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT02573155 Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects Status COMPLETED Phase PHASE1
NCT02572687 A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Status COMPLETED Phase PHASE1